Inside a cancer cell, locked tightly within spools of genetic text, reside the origins of each malignancy. For some cancers, a few misprints here or there enabled them to grow out of control. For others, a new juxtaposition of disparate pieces of genetic code granted the cells immunity from this rapid, malignant growth. The exact […]
CU Cancer Center study: bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle, with diagnostic, prognostic and treatment implications.
The discovery of a biomarker that predicts the response to chemotherapy in patients with the most malignant form of ovarian cancer will help lead to better treatment options.
Researchers have discovered a blood biomarker that is 'highly effective' in distinguishing between people with and without nonsmall cell lung cancer.
The mutation occurs in the androgen-synthesizing enzyme 3Î²HSD1 in castration-resistant prostate cancer (CRPC), according to research published online in Cell. This mutation enables the tumor to make its own supply of androgens, a h...